Pfizer Wins FDA Approval and 4 Dow Movers Sparking Chatter

Chevron Corporation (NYSE:CVX) and Exxon Mobil Corporation have posted solid gains on Wednesday as equities and crude oil futures rallied following a fiscal cliff deal on Capitol Hill. Shares of ExxonMobil jumped 1.5 percent and Chevron by 1.2 percent. The companies are components of the Dow Jones Industrial Average, which rallied 260 points, or 2 percent.

McDonald’s Corporation (NYSE:MCD) said in an e-mail to Global Times that, “Liuhe is a secondary supplier to McDonald’s (in China). As our responsibility to consumers, McDonald’s has temporarily stopped using raw chicken materials from Liuhe Group starting December 18. No chicken product sold in McDonald’s restaurants is tied to Liuhe now.”

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Pfizer (NYSE:PFE) and Bristol-Myers Squibb Company (NYSE:BMY) report that the FDA has approved Eliquis (apixaban) to decrease the risk of stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation. The drug is an oral Factor Xa inhibitor anticoagulant and is expected to be widely available in the United States by the end of January. In 2007, Pfizer and Bristol-Myers Squibb entered into a global partnership through which to develop and commercialize Eliquis, an investigational oral anticoagulant that was discovered by Bristol-Myers Squibb.

General Electric Company’s (NYSE:GE) GE Energy Financial Services is in a consortium that includes MEAG, the asset management division of Munich Re and ERGO, and EDF Energies Nouvelles and is acquiring 32 operating wind farms in France from Iberdrola. The group of onshore wind farms, which are spread across France and were commissioned during 2006 to 2012, have an aggregate capacity of 321.4 megawatts, employing turbines from a variety of manufacturers with the generated electricity sold according to long-term contracts under France’s feed-in tariff. The deal is worth €350 million, plus an earn-out of as much as €50 million, depending on output during the next five years. Upon completion, the wind portfolio’s ownership will be GE Energy Financial Services and MEAG with 40 percent each and EDF Energies Nouvelles with 20 percent.

Don’t Miss: Will Novartis Change the Pharmaceutical Industry?